OPEN LETTER DEMANDS ACTION TO SAFEGUARD PEOPLE WITH ME, NOT JUST POST-COVID PATIENTS

Share on facebook
Share on twitter
Share on email

#MEAction UK have once again written to the National Institute for Health and Care Excellence (NICE) imploring them to act to safeguard people with ME from harm, after their recent statement cautioning that the recommendation of graded exercise therapy should not be assumed to apply to patients with post-COVID symptoms.

Development and publication of the new ME/CFS guideline is now set to take almost 4 years – that is time in which countless more people with ME have been prescribed graded exercise therapy to their detriment. It is functioning and livelihoods lost that may never be recovered. 

Read our open letter to NICE:

Dear Helen Finn,

Thank you for your latest email. We note that NICE has now put out a short statement under the title ‘interim findings’ clarifying that the 2007 recommendation of graded exercise therapy (GET) for people with mild and moderate ME should not be assumed to apply to people with post-COVID fatigue. 

#MEAction UK are pleased to finally see movement from NICE on this issue, but it is still imperative to communicate to you that this step continues to fail people with ME, and will also fail people who develop ME post-COVID.

We are relieved that patients experiencing post-COVID symptoms will not initially be subject to the same harmful recommendation from NICE as people with ME have been for the last 13 years. 

We would like to know on what evidence base you decided to make this statement. At present, we can only be led to assume that you have made this statement based upon the harm that people with ME have experienced, therefore we can see no reason to withhold a similar warning relating to ME itself.

After multiple delays – some unavoidable –  development and publication of the new ME/CFS guideline is now set to take almost 4 years. At every stage #MEAction and other patient organisations have made you aware that the existing guidelines are harmful. The evidence base clearly demonstrates harm. Other countries have already taken steps to end harmful practices. We have sent you individual stories of harm from thousands of people and we have made you aware of the personal impact behind the decision to leave harmful recommendations in place. You are concerned enough to issue a statement saying that GET is not recommended for post-COVID patients and yet you do not seem to have the same concern for people with ME. NICE can choose to act, and we once again implore you to do so.

As we will be publishing this letter and your response on our website and social media, please let us know if anything in your response is to be considered confidential. 

Kind regards,

#MEAction UK

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on google
Google+
Share on email
Email

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest News

#MEAction activists outside Scottish Parliament

Scottish Election! Ask your MSPs to support people with ME

If you live in Scotland, please join our campaign to ask your MSPs to pledge their support for people with ME. Email your MSPs The Holyrood elections are coming up on 6 May 2021 and we want to make sure that MSPs are aware of ME and the desperate need for support. There are more

Read More »
Terri Wilder - #MEAction Activist Camp

#MEAction’s ACTIVIST CAMP! – the Highlights!

It’s a wrap! Last weekend concluded the final session #MEAction’s first ever ACTIVIST CAMP!, a teach-in series for activists in the United States. We are so proud of this program and what it has accomplished. Congrats to our new grads!  #MEAction ACTIVIST CAMP! aimed to deepen our campers’ engagement with activism – teaching our collective

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top